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Abstract
Background: Shaping of the neural tube, the precursor of the brain and spinal cord, involves narrowing and
elongation of the neural tissue, concomitantly with other morphogenetic changes that contribue to this process.
In zebrafish, medial displacement of neural cells (neural convergence or NC), which drives the infolding and
narrowing of the neural ectoderm, is mediated by polarized migration and cell elongation towards the dorsal
midline. Failure to undergo proper NC results in severe neural tube defects, yet the molecular underpinnings of
this process remain poorly understood.
Results: We investigated here the role of the microtubule (MT) cytoskeleton in mediating NC in zebrafish embryos
using the MT destabilizing and hyperstabilizing drugs nocodazole and paclitaxel respectively. We found that MTs
undergo major changes in organization and stability during neurulation and are required for the timely completion of
NC by promoting cell elongation and polarity. We next examined the role of Microtubule-associated protein 1B
(Map1b), previously shown to promote MT dynamicity in axons. map1b is expressed earlier than previously reported, in
the developing neural tube and underlying mesoderm. Loss of Map1b function using morpholinos (MOs) or δMap1b
(encoding a truncated Map1b protein product) resulted in delayed NC and duplication of the neural tube, a defect
associated with impaired NC. We observed a loss of stable MTs in these embryos that is likely to contribute to the NC
defect. Lastly, we found that Map1b mediates cell elongation in a cell autonomous manner and polarized protrusive
activity, two cell behaviors that underlie NC and are MT-dependent.
Conclusions: Together, these data highlight the importance of MTs in the early morphogenetic movements that
shape the neural tube and reveal a novel role for the MT regulator Map1b in mediating cell elongation and polarized
cell movement in neural progenitor cells.
Background
The neural tube, the precursor of the central nervous
system, derives from the neurectoderm through a
process known as neurulation. In anterior regions of
mouse, chick and Xenopus embryos, conserved aspects
of this process entail thickening of the neural ectoderm
to shape the neural plate, elevation of the edges of the
neural plate to form neural folds and convergent exten-
sion of the neural plate that narrows and elongates the
neural ectoderm [1–4] and contributes to neural groove
formation. The neural folds on either side of the neural
plate eventually fuse at the dorsal midline and separate
from the overlying non-neural ectoderm to shape the
neural tube [5]. Mechanisms of teleost neurulation are
often thought to diverge from primary neurulation due
to the initial formation of a solid rod (and hence ab-
sence of a neural groove), which only later cavitates to
give rise to a neural tube [6]. A common misconception
is that the neural rod is assembled from the coalescence
of neurectodermal cells that exhibit mesenchymal proper-
ties (reviewed in [3]), akin to secondary neurulation in
mammals. However, closer examination of this process in
zebrafish revealed that the neural tube derives in fact from
a bilayered neural plate, albeit incompletely epithelialized,
that infolds as a continuous sheet. The two sides of the
neural plate are closely juxtaposed during infolding,
explaining the absence of a neural groove. Thus, medio-
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lateral positions of cells in the deep layer of the neural
plate correlate with dorso-ventral positions in the
neural tube [7, 8]. In this regard, neural tube formation
in zebrafish is similar to primary neurulation in mam-
mals, which also entails the folding of an epithelialized
neural plate.
As in other vertebrates [9-11], the zebrafish neural
plate undergoes neural convergence and extension.
However, in zebrafish, narrowing and elongation of the
neural anlage is not limited to the neural plate stage,
since convergence also drives infolding of the neural
plate to shape the neural rod and extension occurs con-
comitantly with this event. This later convergence event
(referred to henceforth as NC, for neural convergence)
is driven by polarized migration towards the dorsal
midline and cell elongation along the medio-lateral
(prospective apico-basal) axis. Failure to undergo
proper NC, as a consequence of disruption of the pla-
nar cell polarity (PCP) pathway, results in severe neural
tube defects in zebrafish [12], highlighting the import-
ance of this early stage of neural tube formation.
The cellular mechanisms underlying NC were first re-
vealed in Xenopus and zebrafish, owing to early access
and transparency (zebrafish) of the embryo. In Xenopus,
explant assays have revealed that migration of deep
neural cells in the medial neural plate is mediated by
monopolar protrusions (filopodia and lamellipodia) di-
rected towards the midline [11, 13, 14]. We have previ-
ously demonstrated that cells in the zebrafish neural
plate also extend medially-oriented protrusions and
elongate as they converge towards the midline [8].
Narrowing of the neural plate in mice involves cell
elongation [15] and cellular rearrangements [10, 16] that
are driven by polarized apical boundary rearrangement
and bipolar protrusive activity at the basal pole of cells [9].
Thus, the ability of neuroepithelial cells to form polarized
protrusions appears to be an essential and conserved as-
pect of neural tube morphogenesis, the molecular under-
pinnings of which remain poorly understood.
Many inroads have been made in understanding how
the microtubule (MT) network contributes to cell polar-
ity during migration [17]. MTs are dynamic heteropoly-
mers of α- and β-tubulin, existing in alternating states of
active polymerization and depolymerization known as
dynamic instability [18, 19]. These cytoskeletal elements
establish the position of cortical polarity (manifested as
actin-rich lamellipodia in migrating cells) via multiple
pathways [20, 21]. Key to MT-mediated establishment of
cellular asymmetry is the polarized (radial) organization of
these structures, with slow-growing minus-ends anchored
at the centrosome and the faster growing plus-ends clus-
tered at the leading edge, adjacent to the cell cortex [22].
In addition to their role in cell migration, dynamic MTs
play an active role in cell elongation and maintenance of
homeostatic length [23]. The role of stable MTs in cellular
dynamics is less well established.
MT stability and dynamics are regulated in part by
microtubule-associated proteins (MAPs). Members of
the MAP1 family bind along the entire MT lattice.
MAP1B, a founding member of this family, is post-
translationally cleaved into a heavy chain (HC) and a
light chain (LC1) [24]. The heavy chain contains do-
mains for actin, MTs and LC1 binding [25–27] and can
therefore crosslink MTs and microfilaments [28, 29].
The light chain also binds MTs and actin and regulates
the cytoskeleton [30, 31]. MAP1B proteins were first
identified based on their MT-stabilizing properties
[31–33]. However, unlike tau, MAP1B preferably asso-
ciates with dynamic (tyrosinated) MTs, helping to
maintain a pool of dynamic MTs required for axonal
elongation [34, 35]. This activity of MAP1B is con-
trolled by several kinases, including Glycogen synthase
kinase-3β (GSK-3β), which increases MAP1B MT bind-
ing and dynamicity [36]. The poor MT stabilizing prop-
erties of MAP1B combined with its ability to promote
MT dynamics, suggest MAP1B function differs from
the other MAPs [35]. MAP1B is also expressed prior to
other members of this family in the nervous system
[37–40], as it is observed in neuronal progenitors prior
to their last mitotic division [41]. Despite this early expres-
sion and function in promoting MT dynamics, MAP1B
has not been implicated in early stages of neural tube
development.
We investigate here whether zebrafish Map1b plays a
role in the polarized cell movements that shape the
neural rod during NC. Our studies reveal that MTs
undergo major changes during neural tube formation,
as they become progressively more stable and elon-
gated. The perturbation of cell elongation and polarized
migration following nocodazole and paclitaxel treatments
suggests that the regulation of MT stability during NC is
essential for proper completion of this process. To gain
insight into underlying mechanism, we characterized the
function of Map1b, previously shown to promote MT
dynamicity in axons. map1b is expressed earlier than
previously reported, in the developing neural tube and
underlying mesoderm. Loss of Map1b function using
morpholinos (MOs) or δMap1b, encoding a truncated
Map1b protein product, resulted in delayed NC and
duplication of the neural tube, a defect previously ob-
served in PCP mutants in which NC is also defective
[12]. We observed a loss of stable MTs in these em-
bryos that is likely to contribute to the NC defect.
Lastly, we reveal that Map1b mediates cell elongation in a
cell autonomous manner and polarized protrusive activity,
two cell behaviors that underlie NC and are MT-
dependent. Together, these data highlight the importance
of MTs in the early morphogenetic movements that shape
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the neural tube and reveal a novel role for the MT regula-
tor Map1b in mediating cell elongation and polarized cell
movement in neural progenitor cells.
Results
Microtubules undergo dramatic changes during
neurulation
During early stages of neurulation, MTs appear to
undergo global morphological changes. Immunolabel-
ing with anti-β−tubulin (anti-β-tub, a marker for the
total MT population) revealed that at the neural plate
stage (tb-1 som), when neural cells extend polarized
protrusions towards the midline, MTs are distributed
throughout the cytosol (Fig. 1a, a’), consistent with the
radial organization we previously reported [42]. In con-
trast, at the neural keel stage (so named because of the
keel shape adopted by the neural tissue as it transition
from a neural plate to a neural rod, 4–5 som) and
neural rod (12–13 som) stage, MTs organize into long
linear arrays (bundles), which align along the future
apico-basal axis of neural cells, coincident with epithe-
lialization that occurs following NC (Fig. 1b–c’) [43].
The organizational changes observed in MTs suggest
that they become increasingly stable as neurulation
Fig. 1 Microtubules become increasingly stabilized during neurulation. Hindbrain sections of embryos at the neural plate (tb-1 som) (a, a’, d, d’),
neural keel (4–5 som) (b, b’, e, e’) and neural rod (12–13 som) (c, c’, f, f ’) stages immunolabeled with anti-β-tub (total MTs) in green (a–c’) and
anti-glu-tub (detyrosinated MTs) in red (d–f ’). (a’–c’) and (d’–f ’) Higher magnification of boxed areas in (a–c) and (d–f), respectively. Scale bars: 10 μm
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progresses. In order to investigate the distribution of
stable MTs at different stages of neurulation, embryos
were immunolabeled with anti-detyrosinated-tubulin
(glu-tub). Glu-tub antibodies recognize stable, detyrosi-
nated MTs by binding to the exposed carboxy-terminal glu-
tamic acid of α-tubulin (α-tub) in MT polymers [44, 45].
At the neural plate stage, glu-tub labeling is diffuse and
more punctate than β-tub (Fig. 1d, d’). However, by the
neural keel stage (Fig. 1e, e’) detyrosinated MTs organize
into linear structures, which become more accentuated
at the neural rod stage (Fig. 1f, f ’). The distribution of
glu-tub labeling thus implies that detyrosination of
MTs occurs initially in discrete foci along the MT poly-
mers that subsequently expand to include the entire poly-
mer. These observations suggest that stable MTs increase
over time, reaching elevated levels in the epithelialized
neural tube. To quantify the relative abundance of stable
MTs, we analyzed the ratio of glu-tub (stable MTs) to α-
tub (total MTs) at the neural plate (tb), neural keel and
neural rod stages and found this ratio to be highest at the
neural rod stage (Additional File 1: Figure S1).
We next analyzed the distribution of dynamic MTs
using an antibody that specifically recognizes the tyrosi-
nated form of α-tubulin (anti-tyr-tub) [46]. In contrast
to the spotty distribution of glu-tub at the neural plate
and neural keel stages, tyr-tub was abundant and ap-
peared to near fully overlap with the bulk of MTs labeled
with α β-tub (Fig. 2a1–a3, b1–b3), with the exception of
discrete puncta of α tyr-tub labeling that may corres-
pond to depolimerized tyrosinated tubulin (Fig. 2b3). At
the neural rod stage, the overlap remained extensive but
some segments of MT bundles were more intensely la-
beled with anti- β-tub than with anti- tyr-tub (Fig. 2c3,
c3’). These regions may coincide with areas of MT
Fig. 2 Distribution of dynamic microtubules during neurulation. Hindbrain sections of embryos at the neural plate (tb-1 som) (a1–a3), neural keel
(4–5 som) (b1–b3) and neural rod (12–13 som) (c1–c3’) stages immunolabeled with anti-tyr-tub (dynamic MTs) in red (a1, b1, c1, c1’), anti-β-tub
(total MTs) in green (a2, b2, c2, c2’). (a3, b3, c3, c3’) Red-Green overlay (yellow) of images in (a1-c2’) with nuclei labeled in blue using DAPI. (c1’-c3’)
Higher magnification of boxed areas in (c1–c3). Arrows indicate high overlap between anti-tyr-tub and anti-β-tub; arrowheads indicate area of
reduced overlap between these two markers. Scale bars: 10 μm
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stabilization (arrowhead in Fig. 2c3’). Thus, dynamic MTs
represent the bulk of the MT population during NC, while
stable MTs steadily increase over time.
Microtubules are required for NC
The striking increase in the levels of detyrosinated MTs
suggests that the stability of these cytoskeletal elements
is regulated during neural tube development and likely
to be important for neural tube morphogenesis. To test
this, we treated early neural stage (2–3 som) embryos
with nocodazole (17 and 32 μM) or paclitaxel (50 μM),
which destabilize and hyperstabilize MTs respectively,
and analyzed the effect of these drugs on cell behaviors
at the neural keel stage (4–5 som). The efficacy of these
drugs was first confirmed by immunolabeling with anti-β-
tub, which revealed that the linear organization of MTs
was disrupted following both treatments (Additional file 2:
Figure S2).
To analyze the effect of altering MT stability on NC
following nocodazole or paclitaxel treatments, the width
of the neural plate was assessed using dlx3, a gene
expressed at the border of the neural and non neural
ectoderm. While untreated embryos displayed no NC
defects, the neural plates of nocodazole and paclitaxel-
treated embryos were abnormally wide (A,B) (untreated
embryos: 194 μm ± 31 μm, n= 38 embryos; nocodazole-
treated (17μΜ): 276 μm ± 47 μm, n = 34 embryos;
paclitaxel-treated (50 μM): 279 μm ± 47 μm, n = 42 em-
bryos). In order to investigate the underlying cellular
cause for the NC defects, embryos mosaically expressing
cell-surface Green Fluorescent Protein (mGFP) were ex-
posed to nocodazole (17 and 32 μM) or paclitaxel (50 μM)
and imaged in the hindbrain region at the neural keel (4–
5 som) stage. Cells were significantly shortened follow-
ing treatment with nocodazole and paclitaxel (Fig. 3c),
as determined by length-to-width (LWR) ratio mea-
surements (LWR of untreated cells: 4.48 ± 0.3, n = 26
cells from 7 embryos; LWR of nocodazole-treated cells
1.9 ± 0.19, n = 18 cells from 4 embryos; LWR of
paclitaxel-treated cells: 3.0 ± 0.24, n = 30 cells from 7
embryos) (Fig. 3D), indicating sensitivity to perturba-
tions of the MT network that either destabilize or
hyperstabilize MTs.
In order to investigate whether MTs play a role in po-
larized cell migration, time-lapse confocal imaging was
carried out at the neural plate (tb-1 som) stage using
control and nocodazole-treated embryos mosaically ex-
pressing mGFP. Cells from untreated embryos exhibit
an elongated appearance with protrusions oriented medi-
ally, as previously described [8]. In contrast, cells from
nocodazole-treated embryos were rounded in shape and
failed to migrate in a directional manner, as a result of ran-
domized membrane protrusions (Additional files 3 and 4).
This observation suggests that MTs are not required for
the formation of protrusions but are rather implicated in
the proper polarization of these extensions.
Together these findings identify MTs as key mediators
of cell elongation and polarized cell movement during
NC. They further suggest that regulation of MT stability
is tightly controlled during early development, pointing
to a potential role for microtubule-associated proteins
(MAPs) in this process.
Zebrafish map1b is expressed in the developing neural
tube
Mammalian MAP1B is one of the earliest MAPs to be
expressed in the developing nervous system and hence
a good candidate for mediating early morphogenetic
movements during neural tube formation. Gene ontol-
ogy analysis revealed a high level of sequence similarity
between zebrafish Map1b and its orthologues in chick,
mouse, rat and human. The regions of highest conserva-
tion (98 % identity) comprise a stretch of 550 amino acids
in the N-terminus and 120 amino acids in the C-terminus
[31]. Mammalian MAP1B contains two MT-binding do-
mains, each composed of multiple repeats of KKEE or
KKEI/V motifs [26, 30]. Domain analysis of zebrafish
Map1b revealed the presence of the conserved KKE signa-
ture repeats at the N-terminus, in the region encoding the
heavy chain. Furthermore, synteny analysis showed that
zebrafish map1b is located in a conserved region of the
genome.
In order to determine whether zebrafish map1b is
expressed during neurulation, we performed whole-
mount in situ hybridization. We observed that map1b is
broadly distributed at the neural plate (tb-1som), neural
keel (4–5 som) and neural rod (8–10 som) stages
(Fig. 4a–c). Its expression appears to be in a gradient
that is highest in the mesoderm at the neural plate stage
(Fig. 4a). By the neural keel and rod stages the level of
map1b increases and expression expands dorsally, as
map1b is present throughout the developing neural tube
(Fig. 4b, c). To confirm that the signal observed at these
developmental stages is specific, in situ hybridization
using a sense riboprobe was also performed. No labeling
was observed with the latter (Fig. 4a’–c’).
These observations indicate that map1b is expressed
earlier than previously reported, in undifferentiated neural
progenitor cells undergoing NC.
Depletion of Map1b causes NC defects
We next tested whether map1b is required for NC by
performing functional studies using two splice-blocking
MOs (map1b MO1 and map1b MO2, Additional file 5:
Figure S3). RT-PCR analysis confirmed that these
MOs block map1b mRNA splicing (Additional file 5:
Figure S3). We observed that the neural plate of map1b
MO1 (10 ng)- and map1b MO2 (4 and 10 ng)-injected
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embryos were significantly wider than those of uninjected
and standard control MO (4 ng)-injected embryos (unin-
jected: 272 μm ± 11 μm, n = 58 embryos; standard MO:
220 μm ± 7 μm, n = 29 embryos; map1b MO1: 332 μm ±
15 μm, n = 8 embryos; map1b MO2: 319 μm ± 10 μm, n
= 68 embryo; Fig. 5a), suggesting that map1b is required
for NC. A MO targeting pard3 (10 ng), a gene implicated
in later aspects of neural tube development [42, 47], was
used as an additional negative control and confirmed to
not cause an NC defect (pard3-MO: 200 ± 15 μm, n= 14
embryos; Fig. 5a). To further confirm these results, a
translation-blocking map1b MO (MO3) was designed, but
was found to be less effective than the splice-blocking
MO1 at producing a widened neural plate phenotype.
However, co-injection of MO3 (10 ng) with lower con-
centrations of map1b MO1 (4 ng) resulted in a wider
neural plate, which was not observed in embryos
injected with map1b MO1 alone at the suboptimal con-
centration (uninjected embryos: 165 ± 21 μm, n = 10
embryos; map1b MO1 (4 ng): 145 ± 24 μm, n = 13 em-
bryos; map1bMO3 (10 ng): 212 ± 23 μm, n = 26 embryos;
map1b MO1 (4 ng) + MO3 (10 ng); 291 ± 29 μm, n = 24
embryos) (Additional file 5: Figure S3). Therefore, we con-
clude that the neural plate widening we observe is most
Fig. 3 Regulation of microtubule dynamics is required for NC. a Dorsal views of untreated, nocodazole-treated (5 μg/ml) and paclitaxel-treated
(50 μM) embryos labeled by in situ hybridization with the dlx3 riboprobe. Double red arrowheads indicate the width of the neural plate. Scale bar:
100 μm . b Quantification of the neural plate width (μm) in control (untreated) and drug-treated embryos. (*) indicates statistical significance (P <0.001
for untreated vs nocodazole and untreated vs paclitaxel) using a Kruskal-Wallis test followed by Dunn’s post-hoc test. c Quantification of the
length-to-width (LWR) ratio of mGFP-labeled cells in control (untreated), nocodazole-treated, and paclitaxel-treated embryos at the 4–5 som
stage. (*) indicates statistical significance (P <0.001 for untreated vs nocodazole and P <0.01 for untreated vs paclitaxel) using a Kruskal-Wallis test
followed by Dunn’s post-hoc test. d Hindbrain sections of 4–5 som control (untreated), nocodazole-treated and paclitaxel-treated embryos
mosaically expressing mGFP (green). Nuclei are labeled in blue with DAPI. Double arrows indicate cell length. The dotted white line represents
the midline. Scale bar: 10 μm
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Fig. 4 map1b mRNA distribution. Expression of map1b mRNA in hindbrain sections detected by in situ hybridization using anti-sense (a, b and c)
or sense (a’, b’ and c’) probes. (a, a’) neural plate, (b, b’) neural keel, (c, c’) neural rod stage embryos. The neural tissue is delineated by a dotted
line. Scale bar: 20 μm
Fig. 5 map1b depletion causes NC defects. a Quantification of the width of the neural plate (μm). (*) Indicates statistical significance (P <0.01 for
uninjected vs map1b MO2; P <0.001 for uninjected vs δmap1b-injected) using a Kruskal-Wallis test followed by Dunn’s post-hoc test. b Hindbrain
sections of uninjected and map1b MO1-injected embryos at 24hpf, labeled with Phalloidin (cortical actin, green) and DAPI (nuclei, blue). Asterisks
indicate the ventricles of the duplicated neural tube. Scale bar: 10 μm
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likely due to loss of map1b rather than an off-target effect
of the MOs.
The MT-binding affinity and activity of Map1b is
known to be modulated by several kinases, including
Gsk3β [48–50]. Consistent with this model, we observed a
widened neural plate in embryos in which Gsk3β was dis-
rupted with a translation-blocking MO and a synergistic
interaction between Gsk3β and map1b (data not shown).
To evaluate whether map1b disruption results in later
developmental defects, map1b MO1 and MO2 (10 ng)-
injected embryos were imaged at 24 hpf. We observed
a disorganization of the hindbrain region in these em-
bryos, characterized by absence of morphological land-
marks (Additional file 5: Figure S3) that were more
pronounced with MO1 than MO2. Sectioning through
the hindbrain of MO1-injected embryos revealed that
the disorganization was caused by a partial (n = 4 out
of 10 embryos) or full (n = 1 out of 10 embryos) dupli-
cation of the neural tube (Fig. 5b). This striking pheno-
type was first observed in PCP mutants [12] and is
thought to be a consequence of delayed NC [47, 51]. In
addition to the disorganized hindbrain, we observed a
shortened body axis (Additional file 5: Figure S3), a
phenotype often associated with impaired convergent
extension in the axial mesoderm [52].
Truncated Map1b lacking the MT-binding-domain causes
delayed NC
In order to confirm the role of Map1b in mediating NC
using a MO-independent method, we designed a con-
struct based on a mouse mutation thought to function
as a dominant-negative allele [31, 53, 54]. The zebrafish
mutant construct, δmap1b, encodes the first 571 aa of
Map1b, which includes the Map1b light chain (LC1)
binding domain (in the heavy chain region) but not the
MT-binding domain (6A). Mice that are heterozygous
for this mutation have a spectrum of phenotypes in-
cluding slow growth rates and small eyes, while their
homozygous siblings die during embryogenesis [53].
Interestingly, zebrafish embryos injected with δmap1b
RNA (25, 50, 75 and 100 ng/μl) exhibit an increasingly
severe reduction in body and eye size with higher con-
centrations of RNA (Additional file 6: Figure S4B), sug-
gesting that the truncated Map1b protein functions in a
similar manner in both species.
To test whether δMap1b disrupts NC, we injected an
intermediate concentration of δmap1b RNA (50 ng/μl)
and performed the previously described convergence assay.
As was reported for map1b MO1 and MO2-injected em-
bryos, we observed delays in NC in δmap1b-injected relative
to controls (Fig. 5a) (uninjected: 272 μm ± 11 μm, n = 58
embryos vs δmap1b: 355 μm ± 13 μm, n = 45 embryos).
The more severe phenotype in δmap1b-injected
embryos compared to map1b MO-injected embryos
suggests that δMap1b functions in a dominant-negative
manner. Given that δ Map1b retains the ability to bind
to LC1 [31], which is implicated in the regulation of MT
stability and other MT-independent processes [31, 55], it
is likely that depletion of this peptide accounts for some
of the pronounced defects observed in injected embryos.
In addition, the unbound endogenous heavy chain in
δmap1b-injected embryos may also play a contributing
role.
Together these findings reveal a previously unknown
role for Map1b in mediating NC in the neural ectoderm.
The fully or partially duplicated neural tube observed in
map1b MO-injected embryos is consistent impaired NC.
Furthermore, the fact that a neural tube, albeit abnor-
mal, forms in Map1b-depleted embryos indicates that
Map1b is required for the timely progression rather than
completion of neurulation.
Loss of Map1b results in the loss of stable microtubules
Previous studies indicate that Map1b maintains a dy-
namic population of MTs that promotes axonal growth
[48, 56]. If Map1b plays a similar role in the neuroecto-
derm, its loss-of-function should result in increased MT
stability. To test this prediction, neural keel (4–5 som)
stage uninjected, standard MO-injected, map1b MO2-
injected and δmap1b-injected embryos were sectioned
and labeled with anti-β-tub (total MTs), anti-glu-tub
(stable, detyrosinated MTs) and DAPI (nuclei) and
imaged at the hindbrain level. Unlike the dramatic per-
turbation of the MT network observed following treat-
ments with nocodazole and paclitaxel (Additional file 2:
Figure S2), the overall organization of MTs visualized
with β-tub labeling in map1b MO2- and δmap1b-
injected embryos appeared similar to controls (Fig. 6a),
although in some samples (insets in Fig. 6a b1, c1) the
β-tub-labeled bundles were less well defined than those
of uninjected (inset in Fig. 6a a1) and standard MO
(data not shown).
Enhanced MT stability is often manifested in either
an increase in MT bundle length or the average num-
ber of MT bundles/cell. Quantification of the length of
glu-tub- and β-tub-positive bundles in the different
treatment groups did not reveal any differences (data
not shown). However, the average number of stable,
glu-tub-positive bundles per cell (nucleus) revealed an
unexpected decrease in map1b MO2- and δmap1b-
injected embryos relative to uninjected embryos (Fig. 6b)
(uninjected embryos: 3.2 ± 0.23, n = 13 embryos; standard
MO-injected embryos: 2.8 ± 0.69, n = 3 embryos; map1b
MO2-injected embryos: 2.18 ± 0.23, n = 6 embryos;
δmap1b-injected embryos: 2.19 ± 0.27, n = 9 embryos).
Although a decrease in bundle number in experimental
groups relative to standard MO-injected embryos was also
observed, this number was not statistically significant,
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most likely due to the smaller sample size of the latter
(Fig. 6b). These observations suggest that in the context of
NC, Map1b functions to stabilize MTs rather than pro-
mote MT dynamics.
A decrease in total bundle number per cell was also ob-
served with β-tub labeling, but only in δmap1b-injected
embryos (uninjected embryos: 8.16 ± 0.85, n = 14 embryos;
standard MO-injected embryos: 11.5 ± 1.6, n = 5 embryos;
δmap1b-injected embryos: 6.18 ± 0.54, n = 9 embryos)
(Fig. 6c). This reduction is unlikely to reflect the loss of
stable MTs from the total MT population given that a de-
crease in total MTs was not observed in map1b MO2-
injected embryos. Thus, δMap1b may disrupt total MTs
(dynamic and stable) whereas map1b-MO2 alters stable
MTs specifically. However, a more likely explanation, is that
the apparent loss of total MT bundles in δmap1b-injected
embryos reflects subtle changes in the organization of the
MT cytoskeleton (bundles that are less well defined) that
make the automated quantification method less accurate.
To more directly tease apart the role of Map1b in
regulating stable versus dynamic MTs, we also analyzed
the levels and distribution of tyrosinated α-tub (dynamic
MTs) in map1b-MO2- and δmap1b-injected embryos.
We did not observed an obvious difference in the num-
ber and organization of tyr-tub MTs in these embryos
(map1b MO2-injected embryos: n= 4 embryos; δmap1b-
injected embryos: n= 3 embryos) relative to controls
(uninjected embryos: n = 5 embryos). We did however
notice an increase in the number of puncta labeled with
anti tyr-tub (arrowheads in Additional File 7: Figure S5).
Fig. 6 Microtubule stability is altered in Map1b-depleted embryos. a Hindbrain sections of uninjected (a1, a2), map1b MO2-injected (b1, b2) and
δmap1b-injected (c1, c2) embryos at 4–5 som immunolabeled with anti-β-tub (green, a1, b1, c1) and anti-glu-tub (red, a2, b2, c2). Nuclei are labeled in
blue with DAPI. Insets show higher magnification of boxed areas. Scale bars: 10 μm. b Quantification of the average number of glu-tub - labeled
bundles per nucleus in uninjected, standard MO-injected, map1b MO2-injected and δmap1b-injected embryos. (*) Indicates statistical significance
(P <0.05 for uninjected vs map1b MO2 and P <0.05 for uninjected vs δmap1b-injected) using ANOVA followed by a Bonferroni post test.
c Quantification of the average number of β-tub labeled bundles per nucleus in uninjected, standard MO-injected, map1b MO2-injected and
δmap1b-injected embryos. (*) Indicates statistical significance (P <0.01 for standard MO vs δmap1b-injected) using ANOVA followed by a
Bonferroni post test (d) Quantification of the neural plate width in control (uninjected), map1b MO2-injected embryos, nocodazole (3 μΜ)-
treated embryos, and map1b MO1-injected embryos treated with nocodazole
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Since re-tyrosination has been reported to occur on the
non-assembled tubulin dimer pool [57], these puncta
may correspond to depolimerized tubulin. Overall these
observations suggest that loss of Map1b does not impact
dynamic MTs.
To further test whether Map1b is implicated in MT
stabilization, we performed a nocodazole sensitization
test in map1b MO2-injected (4 ng) embryos. However,
treatment of these embryos with a low dose of nocoda-
zole (1 μg/ml) did not worsen NC defects (Fig. 5d).
This may be due to intrinsic differences in the mecha-
nisms by which these molecules alter MT properties.
Alternatively, Map1b may function via additional MT-
independent mechanisms to promote NC.
Map1b functions cell-autonomously to regulate cell
elongation
In order to identify the cellular mechanisms underlying
delayed NC in Map1b-deficient embryos, we analyzed
the morphology of hindbrain cells mosaically expressing
mGFP at the neural keel (4–5 som) stage. We observed
that in contrast to control (uninjected) cells (Fig 6a a–a’),
cells in map1b MO1 (data not shown), map1b MO2- and
δmap1b-injected embryos failed to elongate (Fig. 7a b –
b’, c-c'), as was observed with drug-treated embryos
(Fig. 3c, d). LWR measurements of control and Map1b-
deficient cells revealed a significant difference in cell shape
(LWR of uninjected cells = 3.70 ± 0.1, n = 111 cells from
7 embryos; LWR of cells from embryos injected with
map1b MO2 = 2.78 ± 0.2, n = 43 cells from 5 embryos;
LWR of cells from embryos injected with δmap1b = 2.41
± 0.1, n = 135 cells from 9 embryos) (Fig. 7b). Thus,
Map1b is required for cell elongation during NC and its
ability to regulate MTs may underlie this process.
Since map1b is expressed in the mesoderm and neu-
roectoderm (Fig. 4), it is possible that the widened
neural plate of Map1b-deficient embryos is an indirect
consequence of defective convergent extension move-
ments in the mesoderm [52]. If Map1b functions in a
cell-autonomous manner in the neuroectoderm to regu-
late cell elongation, then Map1b-deficient cells isochroni-
cally transplanted into WT hosts are expected to be
rounded. Conversely, isochronic transplantation of control
(WT) cells into Map1b-deficient embryos should not im-
pact the ability of these donor cells to adopt their correct
elongated morphology.
To perform the first isochronic transplantation ex-
periment, donor embryos were injected with RNA en-
coding mRFP with or without map1b MO1 (10 ng) and
host embryos were injected with mGFP DNA (which is
mosaically expressed). Cell shapes of both donor (red)
and host (green) cells were analyzed in hindbrain
sections of host embryos fixed at the neural keel stage
(4–5 som). We observed that transplanted control cells
were similar in shape to WT host cells (LWR of control
cells = 3.37 ± 0.5, n = 100 cells from 18 embryos; LWR of
host cells = 3.52 ± 0.69, n = 88 cells from 14 embryos;
Fig. 7c, d a–a’), whereas transplanted Map1b-deficient cells
consistently appeared rounder than WT host cells (LWR of
map1bMO1-injected cells = 1.51 ± 0.27, n = 135 cells from
14 embryos; LWR of WT host cells = 3.63 ± 0.52, n = 92
cells from 14 embryos; Fig. 7c, d b–b.2’). There was no
apparent bias to the location of transplanted cells in the
neural tube of their hosts, eliminating position as a
contributing factor to differences in cell shape. These
data reveal that Map1b functions cell autonomously to
regulate cell elongation in the neural ectoderm.
The reciprocal isochronic transplantation could not be
completed as the Map1b-deficient hosts did not survive
the transplantation.
Map1b is required for polarized migration during NC
To test whether Map1b plays a role in polarized cell
migration during NC, mGFP-labeled cells in control
(uninjected) and map1b MO1(10 ng)-injected embryos
were imaged using time-lapse microscopy (Fig. 8a and
Additional files 8 and 9). Cell tracing revealed that
control cells (from uninjected embryos) were initially
rounded and gradually elongated as they approached
the midline. In contrast, cells in map1b MO1-injected
embryos took longer to elongate, consistent with the
LWR measurements of cells in fixed preparations. In
addition, their migration towards the midline was de-
layed (Fig. 8b; n = 3 embryos; 6–9 cells/embryo).
In order to determine whether delayed migration in
map1b MO1-injected embryos was caused by defective
protrusive activity, as observed in drug-treated em-
bryos, the angular distribution of plasma membrane ex-
tensions was quantified and ploted. At the neural plate
(tb-1 som) and neural keel (4–5 som) stages, membrane
protrusions of control cells were biased towards the
medio-lateral axis, whereas the membrane protrusions
in Map1b-deficient cells were less polarized and failed
to align with the medio-lateral axis (Fig. 8c). Together
these findings suggest that Map1b mediates both cell
elongation and the polarized orientation of protrusive
activity, two cell behaviors that are MT-dependent.
Discussion
MTs are required for NC
Cellular dynamics during convergent extension move-
ments in vertebrates are powered by actin polymerization,
cell-cell adhesion and cell-extracellular matrix (ECM) in-
teractions [52]. Since MTs play a prominent role in cell
migration [17, 22], it seems intuitive that they would also
be implicated in the mechanics of cellular rearrangements
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during convergent extension in the mesoderm and neurec-
toderm. There is some experimental evidence supporting
MT-mediated cellular rearrangement in the mesoderm,
however, there is a dearth of data on the involvement of
MTs during NC. With respect to the mesoderm, disrup-
tion with nocodazole in early gastrula Xenopus embryos
prevents mediolateral intercalation, involution and conver-
gent extension of the marginal zone (the precursor of the
mesoderm) [58]. Kwan and Kirschner further demon-
strated that treatment of Xenopus dorsal marginal zone ex-
plants with nocodazole but not taxol prevents
lamellipodia formation, indicating that the bulk of po-
lymerized tubulin rather than MT dynamics (which
would be altered by both drug treatments) is important
for convergent extension [59]. In zebrafish embryos,
MTs are known to mediate cell-cell contacts and initi-
ation of planar polarity, by localizing PCP pathway
component Prickle in a polarized manner during meso-
dermal convergent extension [60].
In amniotes, narrowing of the neural plate is brought
about by a combination of cell elongation and intercal-
ation. In chick embryos, treatment of the neural plate
with nocodazole prevents cell lengthening along the
apico-basal axis, resulting in a wider neural plate [61].
While it is currently unknown whether MTs also power
cell intercalation in amniotes, the medio-lateral oriented
Fig. 7 Map1b functions cell autonomously in the neural ectoderm. a Hindbrain sections of 4–5 som uninjected (a, a’), map1b MO2-injected (b, b’)
and δmap1b-injected (c, c’) embryos mosaically-expressing mGFP (green). Nuclei are labeled in blue with DAPI. (a’–c’) Higher magnification of
boxed areas in (a–c) respectively. Scale bars: 20 μm. b Quantification of the LWR of cells in 4–5 som uninjected, map1b MO2-injected and
δmap1b-injected embryos. (*) Indicates statistical significance (P <0.01 for uninjected vs map1b MO2 and P <0.001 for uninjected vs δmap1b-injected)
using a Kruskal-Wallis test followed by Dunn’s post-hoc test. c Quantification of the LWR of control donor cells vs host WT cells and map1b
MO1-injected donor cells vs host WT cells. (*) Indicates statistical significance (P <0.0001) using Student’s T-test. d Hindbrain sections of 4–5
som WT hosts mosaically-expressing mGFP and transplanted with (a) mRFP-labeled control donor cells or (b) mRFP-labeled map1b-MO1 donor cells.
Nuclei are labeled with DAPI (blue). (a’, b1’ and b2’) Higher magnifications of boxed areas in (a, b1 and b2) respectively. Scale bars: 10 μm
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basal protrusions that drive cellular rearrangement in the
mouse epithelialized neural plate [9] are reminiscent of
MT-dependent polarized basal protrusions in C. elegans
epithelial cells undergoing dorsal closure [62], raising the
possibility that MT-based mechanisms may also be
employed to narrow the neural in chick and mouse
embryos.
We have previously shown that MTs in neural plate
cells have a radial organization, which is characteristic of
migratory cells. Following NC, MTs become linear, an
architecture often observed in epithelial cells [42]. We
report here that the levels of stable MTs steadily increase
as neurulation proceeds. Our functional analysis using
MT-disrupting drugs further suggests that proper regu-
lation of MT stability is essential for both cell elongation
and polarized migration during NC. In addition, the fact
that protrusive activity is still observed (albeit random)
in nocodazole-treated embryos, indicates that MTs are
required for polarization but not the formation of these
membrane extensions.
Thus, despite the more prominent mesenchymal
properties of zebrafish neural plate cells relative to
their amniote counterparts, evidence suggests that
MTs and their regulators play a central role in driving
NC in vertebrates.
Map1b promotes stable microtubules
The prominent changes in MT stability during neurula-
tion are likely to be regulated by microtubule associated
proteins. We show here that stable/detyrosinated MTs
are lost in Map1b-deficient embryos. The apparent se-
lective reduction in detyrosinated MTs (observed in
map1b MO2-injected embryos) argues against a role for
Map1b as a general MT stabilizing factor. Rather, Map1b
may protect stable MTs or promote the α-tub detyrosi-
nation event that is revealed by glu-tub labeling.
Fig. 8 Polarized migration is disrupted in Map1b-depleted embryos. a Selected frames from time-lapse imaging of control (uninjected) and
map1b-depleted mGFP-expressing cells in the neural plate. The white dotted line indicates the dorsal midline, when visible in the imaging field.
Time elapsed (minutes) is indicated in the upper right corner. Red asterisks indicate individual cells identified in multiple frames. Scale bar: 10 μm.
b Representative traces of control and map1b-depleted cells traced over time. Traces corresponding to time 0 (t0 min, green) are to the right and
traces of older cells (t56 min and higher, yellow) are to the left. c Plot of the average distribution of membrane protrusions in representative
mGFP- labeled control and map1b-depleted cells at the neural plate stage. The red dotted line represents the position of the dorsal midline
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Despite the focus on MTs in this study, it is likely that
Map1b also influences the actin cytoskeleton. In this re-
gard, Map1b is known to bind actin in addition to MTs
[25, 63], thereby crosslinking the two cytoskeletons. Fur-
thermore, Rac1 and Cdc42 are downstream effectors of
Map1b [64] that are both implicated in the crosstalk be-
tween actin and MTs [65].
Map1b regulates distinct cell behaviors during NC
We have previously shown that, during NC, cells elong-
ate as they migrate towards the dorsal midline. These
cellular dynamics are accompanied by extensive protru-
sive activity polarized along the medio-lateral axis [8].
Since perturbation of MT dynamics with nocodazole or
paclitaxel prevents cell elongation and polarized migra-
tion in the zebrafish neural plate (this study) and other
contexts [23, 66-71], we investigated whether these cell
behaviors are also altered in Map1b-depleted embryos.
We found that despite the broad distribution of mRNA
in mesodermal and ectodermal cells, Map1b is required
cell autonomously for cell elongation in the neural tissue.
A recent study has shown that a polarized population of
dynamic MTs is required for cell length maintenance in
the zebrafish neural tube [23]. While our studies reveal a
role for Map1b in promoting stable MTs rather than MT
dynamicity, it is likely that both MT populations contrib-
ute to cell elongation.
In addition to cell elongation, directional migration is also
defective in Map1b-depleted embryos. Impaired migration
may also be attributable to abnormal MTs, as stable MTs,
anchored at the cell cortex, are thought to function as
tracks to deliver regulators of actin polymerization to the
leading edge [17]. Whether the same population of Map1b-
regulated MTs mediates cell elongation and migration in
the zebrafish neural tube is unclear.
Analysis of protrusive activity in Map1b-depleted em-
bryos revealed a lack of biased orientation along the
medio-lateral axis and ectopic persistent protrusions on
the anterior and posterior pole of neural cells. This ab-
normal protrusive activity may underlie the delay in cell
elongation and migration. It is unclear how Map1b
biases protrusive activity medially. However, the recent
finding that Map1b binds and sequesters EB3 in the
cytosol of developing neuronal cells [72] raises an inter-
esting possibility. EB3 is a MT-plus end binding protein
that is enriched in growth cones and has been shown to
coordinate the interaction between F-actin (required
for protrusive activity) and dynamic MTs during neuri-
togenesis [73]. Furthermore, EB3-capped MT plus ends
orient towards the leading edge in migrating cells, pos-
sibly in response to an extracellular signal [17]. In this
context, Map1b may regulate polarized protrusive ac-
tivity by controlling the levels of EB3 available to asso-
ciate with MT plus ends. In the absence of Map1b,
increased binding of EB3 to MTs plus ends could cause
the formation of ectopic F-actin nucleation.
Despite the significant increase in neural plate width
in map1b MO-injected embryos, the neural tube even-
tually forms (albeit abnormally), indicative of a delay
rather than blockage of NC. A similar outcome was
also observed following depletion of PCP pathway com-
ponents, suggesting compensatory mechanisms that en-
sure proper completion of neural development.
Whether map1b function during NC is conserved re-
mains to be determined, as neural tube defects have not
been reported in mouse map1b knockouts [74], possibly
due to functional redundancy among MAP family mem-
bers [75, 76] or distinct cellular mechanisms underlying
the narrowing of the neural plate. Despite these differ-
ences, loss of Map1b function in mice also causes a
delay rather than a blockage in neural development [34].
Conclusions
We show that MTs become progressively more stable as
neurulation progresses. Drug treatments that either des-
tabilize or hyperstabilize MTs impair NC by disrupting cell
elongation and polarization, indicating that the regulation
of MT stability is a key event during neural tube develop-
ment. We demonstrate that the microtubule-associated
protein Map1b is broadly expressed during neurulation and
promotes stable MTs. Furthermore, loss of Map1b function
causes a delay in NC, cell autonomous disruption of cell
elongation, impaired directional migration and polarized
protrusive activity. Based on these findings, we propose that
Map1b enables NC at least in part by maintaining a popula-
tion of stable MTs.
Collectively, these studies identify map1b as a key regu-
lator of early morphogenetic movements in the neural
tube. It will be interesting in the future to identify the
signaling pathways that function upstream of Map1b to
control the MTcytoskeleton during NC.
Methods
Zebrafish strains
Studies were performed using wildtype (AB) strains.
All experiments were approved by the University of
Maryland, Baltimore County’s Institutional Animal Care
and Use Committee (IACUC) and were performed ac-
cording to national regulatory standards.
Embryo staging
Staging was done according to [77]. Stages of neurula-
tion were defined as previously described [8].
Cloning of zebrafish map1b
RNA was extracted from 24 hpf AB embryos using TRIzol
(Invitrogen, cat no. 15596–026). cDNA was synthesized
with RETROscript (Invitrogen, cat no. AM1710) and
Jayachandran et al. Neural Development  (2016) 11:1 Page 13 of 18
oligodT primers. Primers were designed to amplify a con-
served, 302 bp region of zebrafish map1b corresponding




PCR was performed using PfuUltra (Agilent Technolo-
gies, cat no. 600385) and products were cloned into PCR
II-TOPO vector (Invitrogen, cat no. K4600-01).
The δmap1b construct, a codon optimized sequence
encoding the first 571 aa of zebrafish Map1b, was syn-
thesized by Genewiz based on the published zebrafish
map1b sequence (accession # XM_003198629). δmap1b
was subsequently subcloned into the pCS2+ vector.
Nucleic acid and morpholino injections
DNA encoding membrane-targeted Green Fluorescent
Protein (mGFP) (Richard Harland, University of California,
Berkeley, CA, USA) and Red Fluorescent Protein (mRFP)
[78] for mosaic expression were prepared using a midi-
prep kit (Macherey-Nagel, cat. no. 740410.10) and injected
(50–200 pg) into one- to eight-cell stage embryos.
For RNA injections, mGFP or mRFP expressing plas-
mids were linearized with NotI and transcribed using
SP6 mMESSAGE mMACHINE kit (Ambion, cat. no.
AM1340). 50 pg of RNA was injected into one- to four-
cell stage embryos.
MOs were synthesized by GeneTools (Philomath, Ore-
gon, USA) and injected into one- to four-cell stage em-
bryos: map1b splice-blocking MO1 (4 or 10 ng), map1b
splice-blocking MO2 (4 or 10 ng), map1b translation
(ATG)-blocking MO3 (10 ng) and, as negative controls,
pard3 (10 ng) and a standard negative control MO rec-
ommended by GeneTools that targets a human beta-
globin intron, causing little change in phenotype in any













Microinjections were performed using a PCI-100 micro-
injector (Harvard Apparatus, Holliston, MA, USA).
Cell transplantation
Transplantation was performed as described in [82].
50–100 cells from donors were transplanted isochroni-
cally into the animal pole of host embryos at the sphere
to dome stage.
Drug treatments
Early neural keel stage (2–3 som) embryos mosaically
expressing mGFP were manually dechorionated and ex-
posed to nocodazole (concentrations ranging from 3
to 32 μM) (Sigma, cat. no. M1404) or paclitaxel (50 μM)
(Sigma, cat. no. T7191) until embryos reached 4–5 som
stage (~30 min) at 28 °C. The embryos were immediately
fixed overnight in 4 % paraformaldehyde (PFA) diluted
in PBS at 4°C.
Time-lapse confocal microscopy
Time-lapse microscopy was performed as previously de-
scribed [83]. Embryos were imaged using a Leica con-
focal microscope (Leica SP5 TCS 4D) at 30 s-1 min
intervals. Images were analyzed using the Leica LAS
software, Image J (NIH) and Adobe PhotoShop.
Labeling and imaging of fixed preparations
For immunolabeling, embryos were fixed for 3 h with
4 % PFA diluted in MAB buffer (80mM KPIPES, 5mM
EGTA, 1mM MgCl2, 0.2 % Triton-X, pH 6.4) at room
temperature. Embryos were then sectioned (40μm, 1500
Sectioning System) and immunolabeling on floating sec-
tions was carried out as in [84].
Antibodies used: mouse anti-β-tubulin (Sigma, Clone:
TUB 2.1) at 1:500; rabbit anti-α-tubulin (Genetex, Clone:
GTX108784) at 1:500; rabbit anti-tyrosinated tubulin
(Millipore, ABT171) at 1:1000; rabbit anti-glu-tubulin
(Millipore, Clone: AB201) at 1:1000 and rabbit anti-GFP
(Invitrogen, cat. no. A11122) at 1:1000. Secondary anti-
bodies conjugated to Alexa 488, Alexa 594, or Cy3 (Mo-
lecular Probes, cat. nos A11001 and A11008; Molecular
Probes cat. A21442; Invitrogen cat. no. A10520) were used
at a 1:500 dilution. Alexa Fluor 488-conjugated Phalloidin
(Invitrogen, cat. no. A12379) at 1:75 and DAPI (Invitrogen,
cat. No. D1306) were used according to manufacturer’s
instructions.
For cell shape analysis, mGFP or mRFP RNA/DNA
injected embryos were sectioned and either imaged dir-
ectly (mRFP) or immunolabeled with anti-GFP prior to
imaging. All fluorescently labeled sections were imaged
using an SP5 confocal microscope (Leica SP5 TCS 4D).
Wholemount in situ hybridization
ISH was conducted as described [85]. Plasmid contain-
ing dlx3 (obtained from Igor Dawid, NIH) was linear-
ized with NotI and T7 polymerase was used to generate
anti-sense probe. map1b (in pCRII-TOPO vector) was
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linearized using NotI and KpnI for sense and anti-sense
probes, respectively. T7 and SP6 polymerases were used
to generate anti-sense and sense probes respectively.
ISH labeled embryos were sectioned and imaged using
a Zeiss Axioscope2 microscope.
Whole cell lysis and Western blotting
~200 embryos were collected, dechorionated, and batch
deyolked as described elsewhere [86] with the following
modifications. After deyolking, cells were vortexed for
one minute in lysis buffer (100 mM PIPES, 0.5 % Noni-
det P-40, 1 mM MgCl2, 2 mM EDTA, 1 mM dithiothei-
trol, 1:100 dilution of Sigma protease inhibitor cocktail,
cat. No. P8340) and centrifuged for 5 min at high speed.
Supernatant was boiled for 5 min in 2x SDS-loading
buffer, run on a 4-20 % Tris-glycine polyacrylamide gel
(BioRad, cat. no. 456–1085) and transferred onto a
nitrocellulose membrane (Pall Corporation, cat. no.
S80209). Blots were blocked in 5 % dry milk dissolved in
PBST (1X PBS, 0.5 % Tween) for 30 min, then incubated
with 1:1000 anti-α-tub (Millipore, clone DM1A) or 1:500
anti-glu-tub (Millipore, Clone: AB201). Blots were then
incubated with 1:1000 anti-mouse or anti-rabbit HRP-
conjugated secondary antibodies (Santa Cruz, cat. nos.
SC-2005 and SC-2004). Blots were developed using an
enhanced chemiluminescence kit (Thermo Scientific,
cat. no. 34079).
Measurements and statistical analysis
Length-to-Width ratios
LWRs were calculated as previously described [8].
Tracing and quantification of cell behaviors
Cell tracing of single cells over multiple time frames was
performed using Metamorph (MolecularDevices).
Protrusion analysis
Stacks of images from time-lapse microscopy were flat-
tened to a single frame per time point using Volocity
v5.5 (Perkin-Elmer) and exported as tifs. Interphase cells
that stayed in frame for the extent of the movie were
selected. Using a plugin created for imageJ (NIH), indi-
vidual cells were threshholded and the outline traced.
Each cell was then divided into 8 segments based on the
centroid and the orientation to the midline. Finally
individual frames were overlaid and any new membrane
extensions were counted for each frame. The percent
protrusions for each section was then calculated and
plotted in Mathematica v9 (Wolfram).
Synteny analysis
Performed using synteny (http://cinteny.cchmc.org/).
Statistical analysis
InStat (GraphPad) was used to run statistical analysis on
data sets. Student’s T-test, ANOVA followed by Bonferroni
or Kruskal-Wallis test followed by Dunn’s post-hoc test
were used to analyze data groups as appropriate.
Quantification of Western band intensity
Band intensity was determined using digital scans
followed by analysis with ImageJ (NIH). The area used
to measure was constant for all experiments.
Quantification of MTs
Measurements of MT bundle length and number of MT
bundles/nuclei were done using Volocity (Perkin-Elmer).
A maximum intensity projection of the total confocal
sections (40 μm) imaged using the Leica SP5 was gener-
ated. The neural keel was cropped to quantify only MT
signal within the neural tissue. Filters that identified nu-
clei (DAPI), stable MTs (glu-tub) and total MTs (β-tub)
based on the standard deviation of intensity was used.
To compensate for objects close together, an automated
algorithm that separates object was run as part of the fil-
ter. The measurements were automatically collected and
analyzed in excel
Additional files
Additional file 1: Figure S1. Microtubule stability increases during
neurulation. (A) Western blot of whole cell lysates blotted for glu-tub
(stable MTs) and α-tub (total MTs) at neural plate (tb-1 som), neural
keel (4–5 som) and neural rod (12 som) stages. Two bands (1) and (2)
are observed for glu-tub. (B) Ratio of stable:total MTs at neural plate
(tb-1 som), neural keel (4–5 som) and neural rod (12 som) stages, calculated
using glu-tub bands 1 and 2 (A). (PDF 83 kb)
Additional file 2: Figure S2. Nocodazole and paclitaxol disrupt
microtubule organization. (a-c’) Hindbrain sections of 4–5 som control
(a, a’), nocodazole-treated (b, b’) and paclitaxel-treated (c, c’) embryos
immunolabeled with anti-β-tub. (a’-c’) Higher magnifications of boxed
areas in panels (a,b and c) respectively. Scale bars: 20 μm. (PDF 8922 kb)
Additional file 3: Time lapse imaging of cell behaviors during NC in
a WT embryo (high magnification). Time-lapse movie (1 min intervals)
of a control, mGFP-labeled embryo imaged from a dorsal view, anterior
towards the top, beginning approximately at the 2–3 som stage and
extending to the 6–7 som stage. (MOV 48 kb)
Additional file 4: Time lapse imaging of cell behaviors during NC in
a nocodazole-treated embryo (high magnification). Time-lapse movie
(1 min intervals) of a nocodazole-treated embryo, mosaically expressing
mGFP, imaged from a dorsal view, anterior towards the top, beginning
approximately at the 2–3 som stage. (MOV 163 kb)
Additional file 5: Figure S3. Efficacy of map1b MOs. (A) Schematic
representation of zebrafish map1b, showing map1b MO1 binding site at
the exon 4- intron 4 splice junction (red line and lettering), map1b MO2
binding site at the intron 4- exon 5 splice junction (blue line and lettering)
and map1b MO3 at the translational start site (green line and lettering).
Exons are represented by black boxes with corresponding numbers on top.
(B) RT-PCR analysis of the region targeted by splice MOs . The upper
(750bp) and lower (300bp) bands correspond to unspliced and spliced
product respectively. (C) Quantification of the width of the neural plate
(tb- 1 som) of control embryos and embryos injected with map1b MO1
(4 ng), map1b MO3 (10 ng) and map1b MO1 (4 ng) + map1b MO3 (10 ng).
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* Indicates statistical significance using a Kruskal-Wallis test followed by
Dunn’s post-hoc test (P <0.05 compared to the rest of the groups). (D)
Side views of 24 hpf uninjected, map1b MO1-injected (10 ng) and
map1b MO2-injected (10 ng) embryos. Black line indicates morphological
defects in the hindbrain region. Anterior is to the left, dorsal is up. Scale bar:
250 μm. (PDF 4983 kb)
Additional file 6: Figure S4. δmap1b construct and RNA titration.
Representation of zebrafish full length Map1b and δMap1b protein
indicating percent amino acid similarity to human ortholog. Black
represents the highest level of homology and white, the lowest. Hatch
marks indicate the MT-binding domain (MTBD). (B) Titration analysis of
δmap1b RNA. Percent of embryos with WT, mild, moderate, severe and
very severe phenotypes are indicated in the table for each concentration of
RNA. (C) 24 hpf embryos correspond to the phenotypic categories in the
table (a: WT, b: mild, c: moderate, d: severe e: very severe). Black arrowhead
indicates missing eye. (PDF 2953 kb)
Additional file 7: Figure S5. Dynamic microtubules appear normal in
Map1b-depleted embryos. Hindbrain sections of embryos at the neural
keel (4–5 som) stage immunolabeled with anti-tyr-tub (dynamic MTs) in
red (a2, b2, c2) anti-β-tub (total MTs) in green (a3, b3, c3). (a1, b1, c1) Red-
Green overlay (yellow) with nuclei labeled in blue using DAPI. Boxed
areas are shown in higher magnification in (a2-c3). Arrowheads indicate
puncta exclusively labeled with anti-tyr-tub. Scale bars: 10 μm. (PDF 9616 kb)
Additional file 8: Time lapse imaging of NC in a WT embryo.
Time-lapse movie (1 min intervals) of a control, mGFP-labeled embryo
imaged from a dorsal view, anterior towards the top, beginning approximately
at the 2–3 som stage and extending to the 6–7 som stage.] (MOV 581 kb)
Additional file 9: Time lapse imaging of NC in a map1b MO1-
injected embryo. Time-lapse movie (1 min intervals) of a map1b MO1
(10 ng)-injected embryo mosaically expressing mGFP, imaged from a
dorsal view, anterior towards the top, beginning approximately at the
2–3 som stage and extending to the 6–7 som stage. (MOV 538 kb)
Abbreviations
Hpf: Hours-post-fertilization; Map1b: Microtubule associated protein 1 b;
MT: Microtubule; MO: Morpholino; NC: Neural convergence; Som: Somites.
Competing interests
The author(s) declare that they have no competing interests.
Authors’ contributions
PJ, VO and SS: performed the majority of the experiments and contributed
to data analysis and manuscript preparation. EH: carried out the analysis of
dynamic changes in MT organization in WT embryos and the initial studies
on the effect of MT-disrupting drugs on cell elongation and migration. EV
and JW worked with SS to perform Map1b loss of function studies using
primarily δmap1b but also map1b MO2 and performed data quantification
for multiple experiments. RJM performed the analysis and quantification of
the protrusive activity, assisted in the quantification of MT stability, carried
out the statitiscal analyses for most experiments and helped to assemble
figures. NSA designed δMap1b and assisted with the molecular work on
this construct. AM characterized the function of Gsk3β. RMB supervised the
research and data analysis and wrote the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
We thank the following people for their technical assistance: Robyn
Goodman (cell transplantation experiments), Jeff Leips (statistical analysis),
Lakshmi Goli (cell tracing) and Tim Ford (figure preparation). We appreciate
the comments of Michelle Starz-Gaiano and Mark Van Doren on the manuscript.
The Leica SP5 confocal microscope was purchased with funds from the National
Science Foundation, grant # DBI-0722569. The research was supported by NIH/
NIGMS grants # GM085290-02S1 to V. Olmo and # GM085290 to R. Brewster. E.
Vital was supported in part by a grant to UMBC from the Howard Hughes
Medical Institute through the Precollege and Undergraduate Science
Education Program, grant # 52008090.
Author details
1Department of Biological Sciences, University of Maryland Baltimore County,
Baltimore, MD, USA. 2Institut de Biologie Paris Seine-Laboratoire
Neuroscience Paris Seine INSERM UMRS 1130, CNRS UMR 8246, UPMC UM
118 Université Pierre et Marie Curie, Paris, France.
Received: 21 July 2015 Accepted: 29 December 2015
References
1. Davidson LA, Keller RE. Neural tube closure in Xenopus laevis involves
medial migration, directed protrusive activity, cell intercalation and
convergent extension. Development. 1999;126(20):4547–56.
2. Morriss-Kay G, Wood H, Chen WH. Normal neurulation in mammals. Ciba
Found Symp. 1994;181:51–63. discussion 63–59.
3. Lowery LA, Sive H. Strategies of vertebrate neurulation and a re-evaluation
of teleost neural tube formation. Mech Dev. 2004;121(10):1189–97.
4. Smith JL, Schoenwolf GC. Further evidence of extrinsic forces in bending of
the neural plate. J Comp Neurol. 1991;307(2):225–36.
5. Colas JF, Schoenwolf GC. Towards a cellular and molecular understanding
of neurulation. Dev Dyn. 2001;221(2):117–45.
6. Reichenbach A, Schaaf P, Schneider H. Primary neurulation in teleosts–
evidence for epithelial genesis of central nervous tissue as in other
vertebrates. J Hirnforsch. 1990;31(2):153–8.
7. Papan C, Campos-Ortega JA. On the formation of the neural keel and
neural tube in the zebrafish Danio (Brachydanio) rerio. Roux’s Arch Dev Biol.
1994;203:178–86.
8. Hong E, Brewster R. N-cadherin is required for the polarized cell behaviors that
drive neurulation in the zebrafish. Development. 2006;133(19):3895–905.
9. Williams M, Yen W, Lu X, Sutherland A. Distinct apical and basolateral
mechanisms drive planar cell polarity-dependent convergent extension of
the mouse neural plate. Dev Cell. 2014;29(1):34–46.
10. Ybot-Gonzalez P, Savery D, Gerrelli D, Signore M, Mitchell CE, Faux CH, et al.
Convergent extension, planar-cell-polarity signalling and initiation of mouse
neural tube closure. Development. 2007;134(4):789–99.
11. Keller R, Shih J, Sater A. The cellular basis of the convergence and extension
of the Xenopus neural plate. Dev Dyn. 1992;193(3):199–217.
12. Ciruna B, Jenny A, Lee D, Mlodzik M, Schier AF. Planar cell polarity signalling
couples cell division and morphogenesis during neurulation. Nature. 2006;
439(7073):220–4.
13. Elul T, Keller R. Monopolar protrusive activity: a new morphogenic cell
behavior in the neural plate dependent on vertical interactions with the
mesoderm in Xenopus. Dev Biol. 2000;224(1):3–19.
14. Elul T, Koehl MA, Keller R. Cellular mechanism underlying neural convergent
extension in Xenopus laevis embryos. Dev Biol. 1997;191(2):243–58.
15. Sausedo RA, Smith JL, Schoenwolf GC. Role of nonrandomly oriented cell
division in shaping and bending of the neural plate. J Comp Neurol. 1997;
381(4):473–88.
16. Wang J, Hamblet NS, Mark S, Dickinson ME, Brinkman BC, Segil N, et al.
Dishevelled genes mediate a conserved mammalian PCP pathway to
regulate convergent extension during neurulation. Development. 2006;
133(9):1767–78.
17. Siegrist SE, Doe CQ. Microtubule-induced cortical cell polarity. Genes Dev.
2007;21(5):483–96.
18. Mitchison T, Kirschner M. Dynamic instability of microtubule growth. Nature.
1984;312(5991):237–42.
19. Desai A, Mitchison TJ. Microtubule polymerization dynamics. Annu Rev Cell
Dev Biol. 1997;13:83–117.
20. Waterman-Storer CM, Worthylake RA, Liu BP, Burridge K, Salmon ED.
Microtubule growth activates Rac1 to promote lamellipodial protrusion in
fibroblasts. Nat Cell Biol. 1999;1(1):45–50.
21. Brandt DT, Grosse R. Get to grips: steering local actin dynamics with
IQGAPs. EMBO Rep. 2007;8(11):1019–23.
22. Kaverina I, Straube A. Regulation of cell migration by dynamic microtubules.
Semin Cell Dev Biol. 2011;22(9):968–74.
23. Picone R, Ren X, Ivanovitch KD, Clarke JD, McKendry RA, Baum B. A
polarised population of dynamic microtubules mediates homeostatic length
control in animal cells. PLoS Biol. 2010;8(11):e1000542.
24. Hammarback JA, Obar RA, Hughes SM, Vallee RB. MAP1B is encoded as a
polyprotein that is processed to form a complex N-terminal microtubule-
binding domain. Neuron. 1991;7(1):129–39.
Jayachandran et al. Neural Development  (2016) 11:1 Page 16 of 18
25. Cueille N, Blanc CT, Popa-Nita S, Kasas S, Catsicas S, Dietler G, et al.
Characterization of MAP1B heavy chain interaction with actin. Brain Res Bull.
2007;71(6):610–8.
26. Noble M, Lewis SA, Cowan NJ. The microtubule binding domain of
microtubule-associated protein MAP1B contains a repeated sequence motif
unrelated to that of MAP2 and tau. J Cell Biol. 1989;109(6 Pt 2):3367–76.
27. Schoenfeld TA, McKerracher L, Obar R, Vallee RB. MAP 1A and MAP 1B are
structurally related microtubule associated proteins with distinct
developmental patterns in the CNS. J Neurosci. 1989;9(5):1712–30.
28. Hirokawa N, Bloom GS, Vallee RB. Cytoskeletal architecture and
immunocytochemical localization of microtubule-associated proteins in
regions of axons associated with rapid axonal transport: the beta, beta'-
iminodipropionitrile-intoxicated axon as a model system. J Cell Biol. 1985;
101(1):227–39.
29. Sato-Yoshitake R, Shiomura Y, Miyasaka H, Hirokawa N. Microtubule-associated
protein 1B: molecular structure, localization, and phosphorylation-dependent
expression in developing neurons. Neuron. 1989;3(2):229–38.
30. Zauner W, Kratz J, Staunton J, Feick P, Wiche G. Identification of two distinct
microtubule binding domains on recombinant rat MAP 1B. Eur J Cell Biol.
1992;57(1):66–74.
31. Togel M, Wiche G, Propst F. Novel features of the light chain of
microtubule-associated protein MAP1B: microtubule stabilization, self
interaction, actin filament binding, and regulation by the heavy chain. J Cell
Biol. 1998;143(3):695–707.
32. Takemura R, Okabe S, Umeyama T, Kanai Y, Cowan NJ, Hirokawa N.
Increased microtubule stability and alpha tubulin acetylation in cells
transfected with microtubule-associated proteins MAP1B, MAP2 or tau.
J Cell Sci. 1992;103(Pt 4):953–64.
33. Vandecandelaere A, Pedrotti B, Utton MA, Calvert RA, Bayley PM.
Differences in the regulation of microtubule dynamics by microtubule-
associated proteins MAP1B and MAP2. Cell Motil Cytoskeleton.
1996;35(2):134–46.
34. Gonzalez-Billault C, Avila J, Caceres A. Evidence for the role of MAP1B in
axon formation. Mol Biol Cell. 2001;12(7):2087–98.
35. Tymanskyj SR, Scales TM, Gordon-Weeks PR. MAP1B enhances microtubule
assembly rates and axon extension rates in developing neurons. Mol Cell
Neurosci. 2012;49(2):110–9.
36. DiTella MC, Feiguin F, Carri N, Kosik KS, Caceres A. MAP-1B/TAU functional
redundancy during laminin-enhanced axonal growth. J Cell Sci. 1996;
109(Pt 2):467–77.
37. Gordon-Weeks PR, Fischer I. MAP1B expression and microtubule stability in
growing and regenerating axons. Microsc Res Tech. 2000;48(2):63–74.
38. Garner CC, Garner A, Huber G, Kozak C, Matus A. Molecular cloning of
microtubule-associated protein 1 (MAP1A) and microtubule-associated
protein 5 (MAP1B): identification of distinct genes and their differential
expression in developing brain. J Neurochem. 1990;55(1):146–54.
39. Calvert R, Anderton BH. A microtubule-associated protein (MAP1) which is
expressed at elevated levels during development of the rat cerebellum.
EMBO J. 1985;4(5):1171–6.
40. Tucker RP, Garner CC, Matus A. In situ localization of microtubule-associated
protein mRNA in the developing and adult rat brain. Neuron. 1989;2(3):1245–56.
41. Cheng A, Krueger BK, Bambrick LL. MAP5 expression in proliferating
neuroblasts. Brain Res Dev Brain Res. 1999;113(1–2):107–13.
42. Hong E, Jayachandran P, Brewster R. The polarity protein Pard3 is required for
centrosome positioning during neurulation. Dev Biol. 2010;341(2):335–45.
43. Musch A. Microtubule organization and function in epithelial cells. Traffic.
2004;5(1):1–9.
44. Wen Y, Eng CH, Schmoranzer J, Cabrera-Poch N, Morris EJ, Chen M, et al.
EB1 and APC bind to mDia to stabilize microtubules downstream of Rho
and promote cell migration. Nat Cell Biol. 2004;6(9):820–30.
45. Westermann S, Weber K. Post-translational modifications regulate
microtubule function. Nat Rev Mol Cell Biol. 2003;4(12):938–47.
46. Gundersen GG, Kalnoski MH, Bulinski JC. Distinct populations of
microtubules: tyrosinated and nontyrosinated alpha tubulin are distributed
differently in vivo. Cell. 1984;38(3):779–89.
47. Tawk M, Araya C, Lyons DA, Reugels AM, Girdler GC, Bayley PR, et al.
A mirror-symmetric cell division that orchestrates neuroepithelial
morphogenesis. Nature. 2007;446(7137):797–800.
48. Goold RG, Owen R, Gordon-Weeks PR. Glycogen synthase kinase 3beta
phosphorylation of microtubule-associated protein 1B regulates the stability
of microtubules in growth cones. J Cell Sci. 1999;112(Pt 19):3373–84.
49. Owen R, Gordon-Weeks PR. Inhibition of glycogen synthase kinase 3beta in
sensory neurons in culture alters filopodia dynamics and microtubule
distribution in growth cones. Mol Cell Neurosci. 2003;23(4):626–37.
50. Hall AC, Brennan A, Goold RG, Cleverley K, Lucas FR, Gordon-Weeks PR, et al.
Valproate regulates GSK-3-mediated axonal remodeling and synapsin I
clustering in developing neurons. Mol Cell Neurosci. 2002;20(2):257–70.
51. Clarke J. Role of polarized cell divisions in zebrafish neural tube formation.
Curr Opin Neurobiol. 2009;19(2):134–8.
52. Roszko I, Sawada A, Solnica-Krezel L. Regulation of convergence and
extension movements during vertebrate gastrulation by the Wnt/PCP
pathway. Semin Cell Dev Biol. 2009;20(8):986–97.
53. Edelmann W, Zervas M, Costello P, Roback L, Fischer I, Hammarback JA, et al.
Neuronal abnormalities in microtubule-associated protein 1B mutant mice.
Proc Natl Acad Sci U S A. 1996;93(3):1270–5.
54. Takei Y, Kondo S, Harada A, Inomata S, Noda T, Hirokawa N. Delayed
development of nervous system in mice homozygous for disrupted
microtubule-associated protein 1B (MAP1B) gene. J Cell Biol. 1997;
137(7):1615–26.
55. Mei X, Sweatt AJ, Hammarback JA. Regulation of microtubule-associated
protein 1B (MAP1B) subunit composition. J Neurosci Res. 2000;62(1):56–64.
56. Trivedi N, Marsh P, Goold RG, Wood-Kaczmar A, Gordon-Weeks PR.
Glycogen synthase kinase-3beta phosphorylation of MAP1B at Ser1260 and
Thr1265 is spatially restricted to growing axons. J Cell Sci. 2005;118(Pt 5):
993–1005.
57. Beltramo DM, Arce CA, Barra HS. Tubulin, but not microtubules, is the
substrate for tubulin:tyrosine ligase in mature avian erythrocytes. J Biol
Chem. 1987;262(32):15673–7.
58. Lane MC, Keller R. Microtubule disruption reveals that Spemann's organizer
is subdivided into two domains by the vegetal alignment zone.
Development. 1997;124(4):895–906.
59. Kwan KM, Kirschner MW. A microtubule-binding Rho-GEF controls cell
morphology during convergent extension of Xenopus laevis. Development.
2005;132(20):4599–610.
60. Sepich DS, Usmani M, Pawlicki S, Solnica-Krezel L. Wnt/PCP signaling
controls intracellular position of MTOCs during gastrulation convergence
and extension movements. Development. 2011;138(3):543–52.
61. Schoenwolf GC, Powers ML. Shaping of the chick neuroepithelium during
primary and secondary neurulation: role of cell elongation. Anat Rec. 1987;
218(2):182–95.
62. Williams-Masson EM, Heid PJ, Lavin CA, Hardin J. The cellular mechanism of
epithelial rearrangement during morphogenesis of the Caenorhabditis
elegans dorsal hypodermis. Dev Biol. 1998;204(1):263–76.
63. Pedrotti B, Islam K. Dephosphorylated but not phosphorylated microtubule
associated protein MAP1B binds to microfilaments. FEBS Lett. 1996;388(2–3):
131–3.
64. Montenegro-Venegas C, Tortosa E, Rosso S, Peretti D, Bollati F, Bisbal M, et al.
MAP1B regulates axonal development by modulating Rho-GTPase Rac1
activity. Mol Biol Cell. 2010;21(20):3518–28.
65. Wittmann T, Waterman-Storer CM. Cell motility: can Rho GTPases and
microtubules point the way? J Cell Sci. 2001;114(Pt 21):3795–803.
66. Bershadsky AD, Vaisberg EA, Vasiliev JM. Pseudopodial activity at the active
edge of migrating fibroblast is decreased after drug-induced microtubule
depolymerization. Cell Motil Cytoskeleton. 1991;19(3):152–8.
67. Liao G, Nagasaki T, Gundersen GG. Low concentrations of nocodazole
interfere with fibroblast locomotion without significantly affecting
microtubule level: implications for the role of dynamic microtubules in cell
locomotion. J Cell Sci. 1995;108(Pt 11):3473–83.
68. Tanaka E, Ho T, Kirschner MW. The role of microtubule dynamics in growth
cone motility and axonal growth. J Cell Biol. 1995;128(1–2):139–55.
69. Grigoriev IS, Chernobelskaya AA, Vorobjev IA. Nocodazole, vinblastine and
taxol at low concentrations affect fibroblast locomotion and saltatory
movements of organelles. Membrane Cell Biol. 1999;13(1):23–48.
70. Stone MC, Nguyen MM, Tao J, Allender DL, Rolls MM. Global up-regulation
of microtubule dynamics and polarity reversal during regeneration of an
axon from a dendrite. Mol Biol Cell. 2010;21(5):767–77.
71. Yang H, Ganguly A, Cabral F. Inhibition of cell migration and cell division
correlates with distinct effects of microtubule inhibiting drugs. J Biol Chem.
2010;285(42):32242–50.
72. Tortosa E, Galjart N, Avila J, Sayas CL. MAP1B regulates microtubule
dynamics by sequestering EB1/3 in the cytosol of developing neuronal cells.
EMBO J. 2013;32(9):1293–306.
Jayachandran et al. Neural Development  (2016) 11:1 Page 17 of 18
73. Geraldo S, Khanzada UK, Parsons M, Chilton JK, Gordon-Weeks PR. Targeting
of the F-actin-binding protein drebrin by the microtubule plus-tip protein
EB3 is required for neuritogenesis. Nat Cell Biol. 2008;10(10):1181–9.
74. Meixner A, Haverkamp S, Wassle H, Fuhrer S, Thalhammer J, Kropf N, et al.
MAP1B is required for axon guidance and Is involved in the development of
the central and peripheral nervous system. J Cell Biol. 2000;151(6):1169–78.
75. Takei Y, Teng J, Harada A, Hirokawa N. Defects in axonal elongation and
neuronal migration in mice with disrupted tau and map1b genes. J Cell
Biol. 2000;150(5):989–1000.
76. Teng J, Takei Y, Harada A, Nakata T, Chen J, Hirokawa N. Synergistic effects
of MAP2 and MAP1B knockout in neuronal migration, dendritic outgrowth,
and microtubule organization. J Cell Biol. 2001;155(1):65–76.
77. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. Stages of
embryonic development of the zebrafish. Dev Dyn. 1995;203(3):253–310.
78. Megason SG, Fraser SE. Digitizing life at the level of the cell: high-
performance laser-scanning microscopy and image analysis for in toto
imaging of development. Mech Dev. 2003;120(11):1407–20.
79. Wei X, Cheng Y, Luo Y, Shi X, Nelson S, Hyde DR. The zebrafish Pard3
ortholog is required for separation of the eye fields and retinal lamination.
Dev Biol. 2004;269(1):286–301.
80. Lee HC, Tsai JN, Liao PY, Tsai WY, Lin KY, Chuang CC, et al. Glycogen
synthase kinase 3 alpha and 3 beta have distinct functions during
cardiogenesis of zebrafish embryo. BMC Dev Biol. 2007;7:93.
81. Eisen JS, Smith JC. Controlling morpholino experiments: don’t stop making
antisense. Development. 2008;135(10):1735–43.
82. Kemp HA, Carmany-Rampey A, Moens C. Generating chimeric zebrafish
embryos by transplantation. J Vis Exp. 2009;29.
83. Jayachandran PHE, Brewster R. Labeling and imaging cells in the zebrafish
hindbrain. J Vis Exp. 2010.
84. Westerfield M. The zebrafish book. A guide for the laboratory use of
zebrafish (Danio rerio). 4th ed. Eugene: University of Oregon Press; 2000.
85. Thisse C, Thisse B, Schilling TF, Postlethwait JH. Structure of the zebrafish
snail1 gene and its expression in wild-type, spadetail and no tail mutant
embryos. Development. 1993;119(4):1203–15.
86. Link V, Shevchenko A, Heisenberg CP. Proteomics of early zebrafish
embryos. BMC Dev Biol. 2006;6:1.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Jayachandran et al. Neural Development  (2016) 11:1 Page 18 of 18
